Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Total Assets
Abbott Laboratories
Total Assets Peer Comparison
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Total Assets
$73.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Assets
$52.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Assets
$35.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Total Assets
$39.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Assets
$15.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
Dexcom Inc
NASDAQ:DXCM
|
Total Assets
$6.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
27%
|
CAGR 10-Years
48%
|
See Also
What is Abbott Laboratories's Total Assets?
Total Assets
73.2B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Total Assets amounts to 73.2B USD.
What is Abbott Laboratories's Total Assets growth rate?
Total Assets CAGR 10Y
6%
Over the last year, the Total Assets growth was -1%.